EMAZOLE Gastro-resistant tablet Ref.[49872] Active ingredients: Esomeprazole

Source: Health Products Regulatory Authority (IE)  Revision Year: 2017  Publisher: Rowex Ltd, Bantry, Co. Cork

Product name and form

Emazole 20 mg Gastro-Resistant Tablets.

Pharmaceutical Form

Gastro-resistant tablet.

20 mg: Light pink oval film-coated tablet.

Qualitative and quantitative composition

Each gastro-resistant tablet contains 20 mg esomeprazole (as magnesium dihydrate).

Excipient(s) with known effect: Each 20 mg gastro-resistant tablet contains 12.90 mg – 14.76 mg sucrose and 0.81 mg glucose.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Esomeprazole

Esomeprazole is the S-isomer of omeprazole and reduces gastric acid secretion through a specific targeted mechanism of action. Esomeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the secretory canaliculi of the parietal cell, where it inhibits the enzyme H+ K+ -ATPase – the acid pump and inhibits both basal and stimulated acid secretion.

List of Excipients

Tablet core:

Sucrose
Maize starch
Liquid glucose
Hydroxypropylcellulose
Povidone
Talc
Titanium dioxide (E171)
Methacrylic acid-ethyl acrylate copolymer (1:1)
Glycerol monostearate
Propylene glycol
Stearic acid
Polysorbate 80
Simeticone
Microcrystalline cellulose
Macrogol 6000
Crospovidone
Silica colloidal anhydrous
Magnesium stearate

Tablet coating:

Hypromellose
Macrogol 6000
Titanium dioxide (E171)
Talc
Iron oxide, red (E172)
Iron oxide, yellow (E172)

Pack sizes and marketing

Aluminium/aluminium blisters and aclar/aluminium blisters with 7, 14, 15, 28, 30, 56, 60, 90, 98, 100 and 100 × 1 gastro-resistant tablets.

HDPE bottles with PP cap and desiccant with 7, 14, 15, 28, 30, 56, 60, 90, 98, 100 and 250 gastro-resistant tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

Rowex Ltd, Bantry, Co. Cork

Marketing authorization dates and numbers

PA0711/158/001

Date of first authorisation: 8th April 2009
Date of last renewal: 2nd April 2014

Drugs

Drug Countries
EMAZOLE Ireland, Malta, Singapore

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.